K

Kiniksa Pharmaceuticals

Biopharmaceutical therapies for debilitating diseases

Group Vice President – Global Regulatory Affairs

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeLexington, MA, USA$360k - $410k

About the Job

Requirements

  • An advanced degree in a relevant scientific, medical, or pharmaceutical discipline: PharmD, PhD, or MS.
  • At least 15 years of progressive Regulatory Affairs experience within the biopharmaceutical industry, including significant senior-level regulatory leadership experience.
  • A proven track record developing and executing U.S. and global regulatory strategies across multiple stages of drug development.
  • Successful leadership of BLA and/or NDA submissions and approvals.
  • Extensive experience leading interactions with FDA and other global Health Authorities.
  • Deep knowledge of global drug development and regulatory requirements, including FDA, EMA, ICH, and global registration pathways.
  • Demonstrated ability to provide strategic regulatory counsel to senior leadership and influence complex cross-functional development and portfolio decisions.
  • Proven ability to build, lead, and develop high-performing regulatory teams.

Responsibilities

  • Define and lead U.S. and global regulatory strategies across development-stage and commercial programs, aligning regulatory pathways with clinical development plans and corporate objectives.
  • Serve as a senior regulatory advisor to executive leadership, providing perspective on regulatory opportunities, precedent, risk, and implications for portfolio and investment decisions.
  • Shape regulatory strategy for early- and late-stage development programs, identifying opportunities to accelerate development and optimize pathways to approval.
  • Provide regulatory leadership in evaluating new therapeutic opportunities, including regulatory due diligence and assessment of development pathways and risks.
  • Lead regulatory strategy for approved products, including global registrations, labeling strategy, lifecycle management, and expansion opportunities.
  • Lead the company's strategy and engagement with FDA, EMA, and other Health Authorities worldwide, including high-impact regulatory interactions, negotiations, and milestone meetings.
  • Establish regulatory positions and ensure the organization is prepared to communicate clear, scientifically grounded strategies to global Health Authorities.
  • Provide senior leadership for major regulatory submissions, including BLAs, NDAs, MAAs, and significant post-approval filings.
  • Serve as the senior regulatory leader across cross-functional development teams, integrating regulatory strategy into clinical, CMC, safety, and commercial decision-making.
  • Make strategic contributions to clinical development plans, including indication strategy, evidence requirements, endpoint considerations, development sequencing, and registration planning.
  • Partner with Clinical Development, Medical, Global Medical Safety, CMC, Commercial, Legal, and other functions to drive timely portfolio decisions.
  • Lead, develop, and scale a high-performing Global Regulatory Affairs organization to support the company's evolving development and commercial portfolio.
  • Provide leadership and oversight to the Global Medical Safety function.
  • Develop regulatory talent and succession capability while fostering accountability, collaboration, urgency, and sound judgment.
  • Establish and maintain regulatory governance, policies, standards, and operating practices that support organizational growth and inspection readiness.
  • Ensure compliance with applicable FDA, EMA, ICH, and global regulatory requirements.

Desired Qualifications

  • MAA and broader global registration experience.
  • Experience with autoimmune, orphan, and/or expedited development programs.
  • Regulatory CMC strategy and leadership experience.
  • Experience leveraging AI or emerging technologies within Regulatory Affairs.

About the Company

Kiniksa Pharmaceuticals

Biopharmaceutical therapies for debilitating diseases

Kiniksa Pharmaceuticals develops and delivers therapies for patients with serious diseases that have few good treatment options. The company focuses on research and development, conducts clinical trials, and then brings approved therapies to market. Its products are created through an R&D process and are intended to be used by patients via the healthcare system, with outcomes measured to help save or improve lives. What sets Kiniksa apart is its patient-centric approach and commitment to urgency and integrity, along with a business model that combines internal R&D with partnerships and licensing to bring therapies to patients. The company aims to improve patient outcomes and quality of life by delivering effective treatments where options are limited.

Company size
201-500
Company stage
IPO
Headquarters
Lexington, KY
Founded
2015

Recently Posted Jobs

Explore more opportunities at Kiniksa Pharmaceuticals

See more jobs